
|Videos|November 9, 2021
A Deep Dive on Tapinarof
Author(s)Mary Scoviak, Managing Editor
In this video interview, Mark Lebwohl, MD, explains why topicals for inflammatory conditions are vital for treatment.
Advertisement
Mark G. Lebwohl, MD, professor of dermatology at Mount Sinai, New York, New York, details how tapinarof cream (GSK2894512; Dermavant), a once-daily topical aryl hydrocarbon receptor (AhR) agonist, is effective for psoriasis, gives his thoughts on the current treatment pipeline, and more in this video interview.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Social Media Mythbusters: The Summer Skin Care "Shutdown"
2
Zasocitinib Shows High Skin Clearance at Hard-to-Treat Psoriasis Sites
3
ED Treatment Gaps Persist for Pediatric Atopic Dermatitis
4
Soficitinib (ICP-332) Meets Primary Endpoint in Phase 3 Trial for Moderate to Severe AD
5











